 |
|
|
| |
EVALUATION AND CLINICAL APPLICATION OF FOSTEMSAVIR CO-ADMINISTRATION WITH TUBERCULOSIS MEDICATIONS
|
| |
| |
Glasgow 2020 Oct 5-8 virtual
Reported by Jules Levin
Katy Moore,1 Dung Nguyen,2 Guoying Tai,2 Mindy Magee,3 Pete Gorycki,2 Taek Lee,4 Peter Ackerman,5
Cyril Llamoso,5 Andrew Clark6
1Clinical Pharmacology, ViiV Healthcare, Research Triangle Park, NC, USA; 2Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Upper Providence, PA, USA;
3Clinical Pharmacology Modeling Simulation, GlaxoSmithKline, Upper Providence, PA, USA; 4PharmD Candidate, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA; 5Clinical Development, ViiV Healthcare, Branford, CT, USA; 6Medical Affairs, ViiV Healthcare, Brentford, UK
|
| |
|
|
|
|
|
